IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

January's CPI report shows inflation is running hotter than the Fed would like, at 3%. That's hard on retirees. Is Social ...

In what appears to be a response to manufacturer complaints regarding “black box” Inflation Reduction Act (IRA) drug price negotiations, the ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

The federal health insurance program has selected 15 additional drugs covered by Medicare Part D for its next round of price ...

President Donald Trump was handed an opportunity to "save" Medicare Advantage after the Biden administration's final proposal ...

In 2025, seniors will pay less for 64 medications if they get them through Medicare Part B, which covers outpatient care, ...

Senator Kirsten Gillibrand announced the Capping Prescription Costs Act, which would limit annual out-of-pocket drug expenses ...

That said, thanks to the Inflation Reduction Act, Medicare Part D enrollees will have a $2,000 cap on out-of-pocket prescription drug spending, so that may help seniors with larger-than-average ...

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

But the Inflation Reduction Act had hidden consequences. When it took effect, there was already a good bit of price competition in Medicare Part D. That’s because most seniors had dozens of ...